Commentary
Recently, there has been interest in the apparent co-incidence of NAFLD in patients with IBS mainly driven by improved understanding of their shared risk factors and pathophysiology.
H. Purssell et al. (Manchester University NHS Foundation Trust, UK) summarise the shared risk factors and describe “how these shared risk factors and etiological factors may have practical clinical implications for these highly prevalent conditions.”
As a conclusion, the authors precise: “patients with known IBS who have abnormal liver function tests or significant risk factors for NAFLD should be investigated appropriately for this possibility. Similarly, IBS should be considered in patients with NAFLD and symptoms of abdominal pain associated with defecation, an altered bowel habit and bloating.”
